MA325G Pharmaceutical Preparations, Except Biologicals

CURRENT INDUSTRIAL REPORTS
2007

MA325G — PHARMACEUTICAL PREPARATIONS EXCEPT BIOLOGICALS (MANUFACTURERS)
DEFINITIONS AND SPECIAL INSTRUCTIONS
Products bought and resold without further
manufacture should not be included in shipments.

1. Scope of survey
This survey covers manufacturers of pharmaceutical
preparations, except biologicals, in the United States,
and includes all preparations which can be dispensed
in measured portions to produce the therapeutic effect
for which the preparation is most commonly employed
(liquids, tablets, pills, capsules, lozenges, powders,
ointments, jellies, salves, inhaler tubes, etc.). Products
manufactured in Puerto Rico or other U.S. possessions
should be excluded.

Establishments shipping dosage forms, in bulk and
requiring repackaging, to other establishments of the
same company, should report in column (4) a transfer
value reflecting only services or operations performed
including profit (or loss) normally assigned to the
manufacturing establishment. For plants shipping
similar products to other companies for repackaging
report in column (4) dosage forms shipped in bulk at
net sales value as defined above.

2. Figures to be reported
Companies with more than one establishment
manufacturing the products covered by this survey are
requested to complete a separate report form for each
location. If you have not received a separate form for
each of your establishments, please call the contact
listed on the report form or write to the U.S. Census
Bureau for additional forms.
Operations for which data should be reported include:
Manufacturing drugs in packaged dosage form for
consumer use
Manufacturing drugs in dosage form and shipping in
"bulk" type containers for repackaging or for export

Commercial shipments (packaged for consumer use)
Report the value of each drug product produced
in dosage form, packaged for consumer use and
shipped from this establishment to sales branches,
warehouses of your company, wholesale or retail
stores, and other commercial customers such as
hospitals, institutions, etc.
Contract operations include shipments of products
made for others from your own materials. Exclude
receipts for capsulating and/or packaging of
preparations owned by others; companies for whom
such work is done should report value of shipments of
these products.
b. Units of measure

Compounding pharmaceutical preparations and
shipping dosage forms in "bulk"

Report values in thousands of dollars.

Please examine the reference list to determine which of
the listed pharmaceuticals are produced by you. If you
are unable to find a specific line which describes a drug
product, include this product in the not elsewhere
classified (n.e.c.) product category at the end of the
product grouping with which it is most closely
associated. In the "n.e.c." products categories, a
separate line should be used to describe and report
each major product. Describe each "n.e.c." product by
using common commercial name, generic name, or
other specific name, and enter any other name,
description, or use that will help to classify the product
using the "Remarks" section for additional space if
necessary.
a. Value of shipments
Report total value of shipments of each pharmaceutical
preparation sold, transferred to other establishments
within your company, or shipped on consignment,
whether for domestic or export sale. Value represents
the net sales price, f.o.b. plant, to the customer or
branch to which the products are shipped, net of
discounts, allowances, freight charges, and returns.
Shipments to your own branches should be assigned
the same value as comparable sales to unaffiliated
customers, i.e., the value includes an appropriate
allocation of company overhead and profit.

c. Columnar structure of report
When posting your figures to the original report, be
sure to report the information in the correct columns.
Column 1 (Total) — Report the sum of columns 2
through 4.
Column 2 (Prescription legend) — Report the value of
each drug product which by Federal Law is available
only by prescription from a licensed practitioner.
Column 3 (Non-prescription) — Report the value of
each non-prescription drug product shipped.
Column 4 (Bulk shipments) — Report the value of each
drug product shipped in dosage forms, or in bulk,
requiring only repackaging.
Note: Export shipments are to be included in these
figures.
3. Definitions
The product detail for this survey, as shown in the
Reference List is defined according to standard
nomenclature for this industry.

USCENSUSBUREAU

Page 1 of 12

CURRENT INDUSTRIAL REPORTS
MA325G

DEFINITIONS AND SPECIAL INSTRUCTION — Continued

4. Comparability
Data reported in this survey should correspond to data reported in the Economic CensusManufacturing Sector Form. The sum of values for item codes shown in column (a) should
correspond to the dollar values reported under product codes indicated in column (b) below:
Current Industrial Reports
(Form MA325G)

Economic Census
Manufacturing Sector

Item codes
(a)

Product codes
(b)

5113 through 5198

3254121100

5211 through 5298

3254124100

5325 through 5397

3254127100

5412 through 5489

325412A100

5511 through 5597

325412D100

5611 through 5698

325412G100

5711 through 5797

325412L100

5811 through 5898

325412P100

5911 through 5997

325412T100

Page 2 of 12

CURRENT INDUSTRIAL REPORTS
REFERENCE LIST
FORM

MA325G

Product
code

PHARMACEUTICAL PREPARATIONS EXCEPT BIOLOGICALS (MANUFACTURERS)
Item
code

Item description

PHARMACEUTICAL PREPARATIONS AFFECTING NEOPLASMS, ENDOCRINE SYSTEM
AND METABOLIC DISEASES, FOR HUMAN USE
Hormones and synthetic substitutes
3254121114

5113

Corticoids, such as cortisone, desoxycorticosterone, hydrocortisone, and prednisone,
including systemic, local and topical (including anti-infective combinations)

3254121121

5117

Androgens, except anabolic agents, such as fluoxymesterone and methyltestosterone

3254121126

5119

Estrogens, such as estradiol and estrone

3254121131

5121

Insulins and anti-diabetic agents such as glucagon and sulfonylureas

3254121141

5127

Oral contraceptive preparations (Report vaginal contraceptives in code 325412D191)

3254121146

5129

Progestogens, such as ethisterone and progesterone (Report premenstrual tension
preps in code 325412D193)

3254121156

5135

Thyroid and antithyroid preparations, such as iodides and propylthiouracil

3254121161

5137

Anabolic agents (synthetic and semisynthetic androgens employed primarily for anabolic
activity), such as nandrolone phenpropionate and norethandrolone

3254121165

5138

Other hormone preparations, such as chorionic gonadotropin, parathyroids,
andvasopressin, ACTH (corticotropni), and Sex hormone combinations (except
progestogen combinations)
Anti-neoplastic agents

3254121177

5146

3254121181

5198

Other pharmaceutical preparations affecting neoplasms, the endocrine system and
metabolic diseases such as metabolic agents, parenteral fats, carbohydrates, and protein
preparations

3254121 --

5199

TOTAL, PHARMACEUTICAL PREPARATIONS AFFECTING NEOPLASMS, ENDOCRINE
SYSTEM AND METABOLIC DISEASES, FOR HUMAN USE

Anti-neoplastic agents, including busulfan, chlorambucil, cyclophosphamide, vincristine
and antimetabolites (folic acid, purine, and glutamine antagonists), and Radioactive
isotopes for internal use

PHARMACEUTICAL PREPARATIONS ACTING ON THE CENTRAL NERVOUS SYSTEM AND
THE SENSE ORGANS, FOR HUMAN USE
3254124111

5211

Parasympathomimetic cholinergic drugs (agents employed mainly for treatment of
myasthenia gravis) such as ambenonium, neostigmine, and pyridostigmine

3254124114

5213

Skeletal muscle relaxants such as methocarbamol and metaxalone
Internal analgesics and antipyretics (Report external analgesics in codes 325412G146 to
325412G161)
Narcotic, such as alphaprodine, meperidine, methadone, and morphine

3254124117

5219

Opium and derivatives

3254124121

5220

Synthetic narcotics

Page 3 of 12

CURRENT INDUSTRIAL REPORTS
REFERENCE LIST — Continued

FORM

MA325G

Product
code

Item
code

Item description

PHARMACEUTICAL PREPARATIONS ACTING ON THE CENTRAL NERVOUS SYSTEM AND
THE SENSE ORGANS, FOR HUMAN USE — Continued
Internal analgesics and antipyretics (Report external analgesics in codes 325412G146 to
325412G161) — Continued
Non-narcotic
3254124122

5221

Salicylates, including Aspirin (acetylsalicylic acid), and others such as sodium
salicylate

3254124131

5225

Aspirin combinations

3254124134

5226

Acetaminophen and combinations

3254124137

5227

Anti-arthritics and anti-inflammatory agents (non-hormonal), such as flunisolide and
fluorometholone

3254124141

5228

Other internal analgesics and antipyretics including effervescent types and
suppositories, such as acetophenetidin, and ethoheptazine

3254124144

5241

Anticonvulsants, except barbiturates and analogs (For treatment of petit mal, grand mal,
psychomotor and focal epilepsy) such as phenytoin, ethotoin, paramethadione, and
methsuximide
Psychotherapeutic agents

3254124147

5251

Antidepressants (for treatment of pyschoneurotic depression, involutional
melancholia, the depressive phase of manic-depressive psychosis and the
depression of schizophrenia), such as imipramine hydrochloride, isocarboxazid, and
maprotiline
Tranquilizers (for treatment of emotional instability and anxiety-tension states).
Report sedatives in codes 3254124171 to 3254124181

3254124151

5255

Phenothiazine derivatives, such as promazine, prochlorperazine, and thioridazine

3254124154

5257

Other tranquilizers, such as chorprothixene and molindone

3254124157

5259

3254124165

5265

Other psychotherapeutic agents
Central nervous system stimulants, including amphetamine, anorexiants containing CNS
stimulants such as phenylpropanolamine hydrochloride, except amphetamines (Report
diet aids containing local anesthetics in code 3254124189), and other, (respiratory and
cerebral stimulants, including sympathomimetic agents employed mainly as CNS
stimulants) (exclude nondrug dietaries for weight control)

Page 4 of 12

CURRENT INDUSTRIAL REPORTS
REFERENCE LIST — Continued
FORM

MA325G

Product
code

Item
code

Item description

PHARMACEUTICAL PREPARATIONS ACTING ON THE CENTRAL NERVOUS SYSTEM AND
THE SENSE ORGANS, FOR HUMAN USE — Continued
Sedatives, anxiolytics and hypnotics (products primarily used for sedation) (Report
products combined with sedative agents under the primary therapeutic indication)
Prescription
3254124171

5271

Barbiturates, such as amobarbital, butabarbital, pentobarbital, and phenobarbital

3254124174

5275

Non-barbiturates, such as ethchlorvynol, glutethimide, and methyprylon.

3254124178

5278

Non-prescription sleep inducers (excluding antihistamines), and calming agents such
as scopalomine

3254124189

5287

Anesthetics except urinary tract anesthetics and antipruritic skin preparations, including
general, local, and topical, such as proparacaine, piperocaine, benoxinate, and
ethylaminobenzoate (Report urinary tract anesthetics in code 325412D196, and
antipruritics in code 325412G116)
Eye and ear preparations (excluding anti-infectives corticoids, anti-bacterials and
antiseptics) (Report antibiotics, sulfonamides, and other anti-infectives in codes
325412P111 to 325412P174; local and topical corticoid preparations in code 3254121116;
and anti-bacterials and antiseptics including mouthwashes and gargles in codes
325412P177 and 325412P181)

3254124193

5293

Contact lens solutions

3254124196

5295

Other eye and ear preparations, including mydriatics and miotics

3254124197

5298

Other pharmaceutical preparations acting on the central nervous system and the sense
organs

3254124 --

5299

TOTAL, PHARMACEUTICAL PREPARATIONS ACTING ON THE CENTRAL NERVOUS
SYSTEM AND THE SENSE ORGANS, FOR HUMAN USE
PHARMACEUTICAL PREPARATIONS ACTING ON THE CARDIOVASCULAR SYSTEM, FOR
HUMAN USE

3254127118

5325

Anticoagulants (for the prophylaxis and treatment of intravascular clotting, thrombophlebitis
pulmonary embolism, arterial thromboses, and coronary occlusion) such as anisindione,
heparin, and warfarin, hemostatics (for control of capillary, venous, or arterial bleeding)
such as thrombin and aminocaproic acid), and digitalis preparations such as digitalis,
digitoxin, and digoxin

Page 5 of 12

CURRENT INDUSTRIAL REPORTS
REFERENCE LIST — Continued
FORM

MA325G

Product
code

Item
code

Item description

PHARMACEUTICAL PREPARATIONS ACTING ON THE CARDIOVASCULAR SYSTEM, FOR
HUMAN USE — Continued
Hypotensives
3254127128

5345

Hypotensives such as guanethidine, hydralazine, and methyldopa, rauwolfia-alkaloid
preparations such as reserpine and rescinnamine, and rauwolfia-diuretic combinations,
and beta receptor blocking agents, such as propanolol hydrochloride
Vasodilators

3254127143

5353

Coronary (for treatment of angina pectoris) including amylnitrite, erythrityl tetranitrate,
and pentaerythritol tetranitrate, and peripheral (for relief of vasospasm) including
isoxuprine and cyclandelate

3254127151

5361

Anti-arrhythmics, such as propanolol and quinidine

3254127156

5371

Calcium channel blockers such as isoptin, calan, procardia, cardizem and adalat

3254127161

5381

Ace inhibitors such as vasotec, capoten, prinivil and zestril

3254127166

5397

Other pharmaceutical preparations acting on the cardiovascular system including
vasopressors, and antiheparin agents

3254127 --

5399

TOTAL, PHARMACEUTICAL PREPARATIONS ACTING ON THE CARDIOVASCULAR
SYSTEM, FOR HUMAN USE
PHARMACEUTICAL PREPARATIONS ACTING ON THE RESPIRATORY SYSTEM, FOR
HUMAN USE

325412A113

5412

Antihistamines, except cold preparations and anti-emetics such as brompheneramine,
diphenhydramine, diphenylpyraline, and chlorpheneramine maleate, and bronchial dilators
including antiasthmatics (for the relief of bronchial spasm or congestion such as
theophylline
Cough and cold preparations (prescription)

325412A123

5423

Cough preparations and expectorants (containing an antitussive or other ingredient
intended primarily to treat cough only), including non-narcotic, and narcotic such as
benzonatate, glycerylguaiacolate, terpin hydrate, codeine, and hydro codeine
Cold preparations (containing combinations of the following ingredients, (but no
antitussive) nasal decongestant, antihistamine, analgesic, bioflavanoid, or antibiotic)

325412A136

5435

Antihistamine cold preparations, such as tripelennamine and cyproheptadine

325412A143

5438

Other prescription cold preparations, including nasel decongestants, such as
proplhexadrine

325412A146

5441

Cough and cold combinations (prescription)

Page 6 of 12

CURRENT INDUSTRIAL REPORTS
REFERENCE LIST — Continued
FORM

MA325G

Product
code

Item
code

Item description

PHARMACEUTICAL PREPARATIONS ACTING ON THE RESPIRATORY SYSTEM, FOR
HUMAN USE — Continued

325412A153
325412A166
325412A171
325412A176
325412A189

5452
5461
5463
5465
5478

325412A196

5489

325412A –

5499

Cough and cold preparations (non-prescription)
Decongestants, including nasal sprays, nose drops, and others
Cough syrups
Capsules and tablets
Lozenges
Other non-prescription cough and cold preparations, including topical preparations, and
cough drops

Other pharmaceutical preparations acting on the respiratory system, including beta
agonists such as proventil and ventolin
TOTAL, PHARMACEUTICAL PREPARATIONS ACTING ON THE RESPIRATORY
SYSTEM, FOR HUMAN USE
PHARMACEUTICAL PREPARATIONS ACTING ON THE DIGESTIVE OR THE GENITOURINARY SYSTEMS, FOR HUMAN USE
Digestive system preparations

325412D111

5511

Enzymes such as amylase, lipase, cellulase

325412D115

5517

Antacids including acid neutralizing products and products with coating functions, but
excluding effervescent salicylate products classified as analgesics, such as aluminumhydroxide, calcium carbonate, dihydroxy aluminum aminoacetate, and aluminumphosphate (Report internal analgesics in code 3254124141), and antidiarrheals such as
bismuth subcarbonate (except narcotics)
Laxatives such as bisacodyl, cascara sagrada, castor oil, danthron, dioctyl sodium
sulfosuccinate, magnesium sulfate, methylcellulose, sodium carboxymethylcellulose, and
petrolatum (liquid)

325412D121

5521

Irritants

325412D123

5522

Bulk producing, and emollients

325412D127

5525

Fecal softeners

325412D134

5528

Saline

325412D137

5529

Enema specialties

Page 7 of 12

CURRENT INDUSTRIAL REPORTS
REFERENCE LIST — Continued
FORM

MA325G

Product
code

Item
code

Item description

PHARMACEUTICAL PREPARATIONS ACTING ON THE DIGESTIVE OR THE GENITOURINARY SYSTEMS, FOR HUMAN USE — Continued
Digestive system preparations — Continued
Antispasmodics and anticholinergics, including ataractic combinations, belladonna and
derivatives, and H2 blocking agents such as zantec, tagamet, carafate, and pepcid

325412D157

5541

Synthetics (such as adiphenine, anisotropine, dicyclomine, and papaverine)

325412D168

5548

Antispasmodics and anticholinergics, including ataractic combinations, belladonna and
derivatives, and H2 blocking agents such as zantec, tagamet, carafate, and pepcid

325412D175

5559

Other digestive system preparations including emetics such as ipecac, including
Digestants; Bile therapy preparations including bile products, choleretics, and
cholagogues; Antinauseants and motion sickness remedies (anti-emetics) including
antihistaminic anti-emetic preparations; Lipotropics and cholesterol reducers; and Diet
aids containing local anesthetics such as benzocaine. (Report anorexiants containing
CNS in codes 3254124165)

Genito-urinary preparations
325412D177

5561

Urinary antibacterials and antiseptics such as methenamine mandelate, and
nitrofurantoin

325412D182

5575

Diuretics, including chlorthalidone, ethacrynic acid, and triampterene, thiazides and
related agents such as chlorothiazide, hydrochlorothiazide, and hydroflumethiazide
(report aminophylline, xanthine, and rauwolfia-diuretic combinations ascardiovascular
preparations)

325412D187

5581

Oxytocics such as ergonovine and oxytocin

325412D195

5587

Vaginal cleansers (Report trichomonacides in code 325412P111, fungicides in code
325412P167, and antibacterials in code 325412P177)

325412D196

5597

Other pharmaceutical preparations acting on the genito-urinary system including urinary
tract anesthetics, including premenstrual tension preparations, and contraceptive agents
(aerosols, jels, sponges, and creams)(Report oral in code 3254121141)

325412D --

5599

TOTAL, PHARMACEUTICAL PREPARATIONS ACTING ON THE DIGESTIVE OR THE
GENITO-URINARY SYSTEMS, FOR HUMAN USE

Page 8 of 12

CURRENT INDUSTRIAL REPORTS
REFERENCE LIST — Continued
FORM

MA325G

Product
code

Item
code

Item description

PHARMACEUTICAL PREPARATIONS ACTING ON THE SKIN, FOR HUMAN USE
Dermatological preparations
325412G111

5611

Emollients and protectives including burn remedies and ointment bases

325412G116

5613

Antipruritics and local anesthetic skin preparations (products used primarily to alleviate
itching), such as cyclomethylcaine and benzocaine

325412G126

5616

Antiacne preparations

325412G131

5618

Antidandruff and antiseborrheic preparations, except dandruff shampoos

325412G138

5620

Other dermatological preparations, including coal tar, sulfur, and resorcinol preparations

325412G141

5621

Hemorrhoidal preparations

325412G163

5638

External analgesics and counter irritants, including ointments, jellies, pastes, creams,
cerates, salves, liquids, and rubbing alcohol

325412G166

5698

Other pharmaceutical preparations acting on the skin

325412G --

5699

TOTAL, PHARMACEUTICAL PREPARATIONS ACTING ON THE SKIN, FOR HUMAN USE
VITAMIN, NUTRIENT, AND HEMATINIC PREPARATIONS, FOR HUMAN USE
Vitamins

325412L111

5711

Multivitamins, plain and with minerals, except B complex vitamins and fish liver oils

325412L116

5713

Pediatric vitamin preparations (drops, suspensions, and chewable tablets)

325412L121

5714

Prenatal vitamin preparations

325412L126

5715

B complex preparations

325412L135

5718

All other vitamin preparations, including fluoride preparations (Report fluoride-vitamin
combinations in applicable code 315412L116, 325412L121, or 325412L135)

325412L141

5721

Fish liver oils

325412L146

5731

Nutrients excluding therapeutic dietary foods and infant formulas

325412L151

5741

Tonics and alteratives
Hematinic

325412L158

5752

Oral, and parenteral, with B12

Page 9 of 12

CURRENT INDUSTRIAL REPORTS
REFERENCE LIST — Continued
FORM

MA325G

Product
code

Item
code

Item description

VITAMIN, NUTRIENT, AND HEMATINIC PREPARATIONS, FOR HUMAN USE — Continued
Hematinics — Continued
325412L168

5756

325412L179

5797

Other vitamin, nutrient, and hematinic preparations, including hospital solutions
(including dextrose, dextran, etc., but excluding biologicals such as blood plasma)

325412L--

5799

TOTAL, VITAMIN, NUTRIENT AND HEMATINIC PREPARATIONS, FOR HUMAN USE

Other hematinics, including oral, and parenteral

PHARMACEUTICAL PREPARATIONS AFFECTING PARASITIC AND INFECTIVE DISEASES,
FOR HUMAN USE
Anti-infective agents (Report corticoid-anti-infective combinations in code 3254121116)
325412P111

5811

Amebicides and trichomonicides such as diiodohydroxyquin, emetine, metronidiazole, and
furazolidone

325412P114

5815

Anthelmintics (for roundworms, hookworms, pinworms, whipworms, and tapeworms) such
as dithiazanine, hexylresorcinol, piperazine, and tetrachloroethylene
Systemic antibiotic preparations
Broad and medium spectrum (single or in combinations with other antibiotics)

325412P117

5820

Tetracyclines, including chlortetracycline and congeners

325412P121

5822

Cephalosporins, such as cefamandole nafate and cephalexin

325412P124

5824

Erythromycins
Penicillins (single)
Semisynthetic penicillins, such as amoxicillins and ampicillin

325412P127

5826

Injectable

325412P131

5828

Other forms

325412P135

5831

325412P141

5834

325412P144

5836

Antibiotics in combination with sulfonamides

325412P147

5838

Other systemic antibiotic preparations, including narrow-spectrum antibiotics and
streptomycins

325412P151

5841

Other penicillins, injectable and other forms (except semisynthetic), such as
penicillin V and penicillin G
Other broad and medium spectrum antibiotics (except sulfa-antibiotic combinations)

Topical antibiotic preparations

Page 10 of 12

CURRENT INDUSTRIAL REPORTS
REFERENCE LIST — Continued
FORM

MA325G

Product
code

Item
code

Item description

PHARMACEUTICAL PREPARATIONS AFFECTING PARASITIC AND INFECTIVE DISEASES,
FOR HUMAN USE — Continued
Anti-infective agents (Report corticoid-anti-infective combinations in code 3254121116) —
Continued
325412P156

5853

Tuberculostatic agents, including isoniazid (isonicotinic acid hydrazide) preparations,
aminoslicylic acid, capreomycin, and cycloserine

325412P161

5861

Antimalarials (plasmodicides) such as chloroquine, primaquine, pyrimethamine, and
quinine

325412P164

5863

Sulfonamides, such as sulfamerazine, sulfamethizole, and sulfadiazine (except sulfaantibiotic combinations)

325412P167

5865

Antifungal preparations such as iodochlorhydroxyquin

325412P171

5867

Antivirals, systemic, such as zovirax and retrovir

325412P174

5869

Other anti-infective agents
Antibacterials and antiseptics (Report urinary preparations in code 325412D177,
antibiotics in codes 325412P117 to 325412P151, and sulfonamides in code 325412P164)

325412P177

5871

General

325412P181

5875

Mouth and throat preparations, including mouthwashes and gargles

325412P184

5898

Other pharmaceutical preparations affecting parasitic and infective diseases

325412P --

5899

TOTAL, PHARMACEUTICAL PREPARATIONS AFFECTING PARASITIC AND INFECTIVE
DISEASES, FOR HUMAN USE
PHARMACEUTICAL PREPARATIONS FOR VETERINARY USE
(Note: INCLUDE drug and vitamin pre-mixes for use in animal feeds; EXCLUDE
supplements, concentrates, and complete feeds)

325412T111
325412T116

5911
5921

325412T126
325412T133
325412T136
325412T163

5924
5925
5927
5937

Anesthetics
Anthelmintics
Antibiotics
Penicillins
Other antibiotics, including tetracyclines
Antiseptics, wound dressings and fungicides
Hormones, including insulin, ACTH (corticotropin), and other hormone preparations

Page 11 of 12

CURRENT INDUSTRIAL REPORTS
REFERENCE LIST — Continued

FORM

MA325G

Product
code

Item
code

Item description

PHARMACEUTICAL PREPARATIONS FOR VETERINARY USE — Continued
325412T171

5941

Nitrofurans

325412T176

5943

Nutrients and tonics

325412T181

5945

Parasiticides, external

325412T196

5997

Other pharmaceutical preparations for veterinary use, including vitamins, minerals,
tranquilizers, ataractics, sulfonamides, intravenous solutions, electrolytes, hemostatics,
and hematinics

325412T --

5999

TOTAL, PHARMACEUTICAL PREPARATIONS FOR VETERINARY USE

NOTES:

10/22/07

Page 12 of 12